Catholic Mental Health Professionals React to Executive Order Removing Barriers to Psychedelic Drugs

PeopleImages
Trump’s executive order instructs the Food and Drug Administration (FDA) to issue priority funding to psychedelic drugs that have received Breakthrough Therapy designation, speeding up reviews that could otherwise take months.

The executive order notes that more than 14 million American adults now suffer from serious mental illness, a large rise from a decade ago.

Read original article